#United States #New York #Levi & Korsinsky #Biohaven Ltd #BHVN

Key Information for Biohaven Ltd. Shareholders

In an important announcement, Levi & Korsinsky, LLP is advising shareholders of Biohaven Ltd. (NYSE: BHVN) regarding a potential class action lawsuit, urging them to make contact before September 12, 2025. This alert is crucial for those who may have suffered financial losses during a specific timeline due to alleged securities fraud.

Details of the Lawsuit

The class action seeks to represent investors negatively impacted by false statements regarding the company's product candidate, Troriluzole. The allegations specifically involve claims made between March 24, 2023, and May 14, 2025. According to the lawsuit, the defendants overstated both the regulatory prospects of Troriluzole and the efficacy of another candidate, BHV-7000, for treating bipolar disorder.

What is at Stake?

The claims suggest that the misleading public statements could have significant repercussions on Biohaven's business and financial health. As the lawsuit unfolds, it's been emphasized that investors who wish to be a part of the recovery process must contact Levi & Korsinsky and express their interest by the September deadline. Importantly, participation in the lawsuit does not necessitate serving as the lead plaintiff, allowing many investors to engage without additional burdens.

No Financial Risk to Investors

For those designated as class members, the lawsuit entails no out-of-pocket costs. Rather, it stands as an opportunity for compensation, allowing investors to potentially recover losses without incurring any fees or associated risks.

Why Choose Levi & Korsinsky?

With over two decades of experience in securities litigation, Levi & Korsinsky has successfully secured substantial amounts for harmed shareholders. Their proven track record is highlighted by consistent rankings in industry reports, such as ISS Securities Class Action Services' Top 50 Report over the last seven years. Their dedicated team, consisting of more than 70 professionals, is well-equipped to navigate complex securities cases, ensuring that investors receive the legal representation they deserve.

Contact for More Information

Shareholders are encouraged to reach out for further details. You can contact Joseph E. Levi, Esq., at Levi & Korsinsky, LLP, via email at [email protected] or by calling (212) 363-7500. Address inquiries to:

Levi & Korsinsky, LLP
33 Whitehall Street, 17th Floor
New York, NY 10004

This is a critical time for Biohaven Ltd. shareholders affected by the alleged fraud. Make sure to act by the September 12 deadline to protect your interests.

Conclusion

As the situation evolves, staying informed and proactive is key for investors. Engaging with experienced legal firms like Levi & Korsinsky can provide the necessary guidance to navigate these challenges effectively. Don't miss this opportunity to seek justice and compensation for your losses.

Remember, the window of opportunity closes on September 12, 2025. Make your voice heard and ensure your rights are protected.